An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Using advanced gene targeting methods, generating mouse models of cancer that accurately reproduce the genetic alterations present in human tumors is now relatively straightforward. The challenge is to determine to what extent such models faithfully mimic human disease with respect to the underlying molecular mechanisms that accompany tumor progression. Here we describe a method for comparing mouse models of cancer with human tumors using gene-expression profiling. We applied this method to the analysis of a model of Kras2-mediated lung cancer and found a good relationship to human lung adenocarcinoma, thereby validating the model. Furthermore, we found that whereas a gene-expression signature of KRAS2 activation was not identifiable when analyzing human tumors with known KRAS2 mutation status alone, integrating mouse and human data uncovered a gene-expression signature of KRAS2 mutation in human lung cancer. We confirmed the importance of this signature by gene-expression analysis of short hairpin RNA-mediated inhibition of oncogenic Kras2. These experiments identified both a pattern of gene expression indicative of KRAS2 mutation and potential effectors of oncogenic KRAS2 activity in human cancer. This approach provides a strategy for using genomic analysis of animal models to probe human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p-Values are adjusted to account for multiple hypothesis testing [34].”
From A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas (2005) · cites this paper as [34]
Citations
Cites
Wu, Y. (1999) · Technometrics · doi:10.1080/00401706.1999.10485951 · Cited by 27,221
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Self-citationDalapicolla, J., do Prado, J. R., Percequillo, A. R., & Knowles, L. L. (2021) · Journal of Biogeography · doi:10.1111/jbi.14281 · Cited by 11,461
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationEGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“The importance of limiting ERK signaling in Ras-induced tumorigenesis is suggested by the facts that overexpression of Ras in vitro causes cellular senescence and that this effect is mediated by the MAPK pathwa”
BackgroundBhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191502998 · Cited by 2,576
Self-citationA molecular signature of metastasis in primary solid tumors
Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,449
Self-citation
Cited by
Items 101–200 of 404
Tian, S., Simon, I., Moreno, V., Roepman, P., Tabernero, J., Snel, M., van't Veer, L., Salazar, R., Bernards, R., & Capella, G. (2013) · Gut · doi:10.1136/gutjnl-2012-302423 · Cited by 128
Lung cancer risk prediction: A tool for early detection
Cassidy, A., Duffy, S. W., Myles, J. P., Liloglou, T., & Field, J. K. (2006) · International Journal of Cancer · doi:10.1002/ijc.22331 · Cited by 134
Genetically Engineered Mouse Models: Closing the Gap between Preclinical Data and Trial Outcomes
Singh, M., Murriel, C. L., & Johnson, L. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2786 · Cited by 125
Maraver, A., Fernández-Marcos, P. J., Herranz, D., Cañamero, M., Muñoz‐Martín, M., Goméz-López, G., Mulero, F., Megı́as, D., Sänchez‐Carbayo, M., Shen, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.014 · Cited by 122
Creighton, C. J., Cordero, K. E., Larios, J. M., Miller, R. S., Johnson, M. D., Chinnaiyan, A. M., Lippman, M. E., & Rae, J. M. (2006) · Genome biology · doi:10.1186/gb-2006-7-4-r28 · Cited by 122
The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling
Okada, T., Sinha, S., Esposito, I., Schiavon, G., López-Lago, M. A., Su, W., Pratilas, C. A., Abele, C., Hernandez, J. M., Ohara, M., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3082 · Cited by 116
Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer
Graveel, C. R., DeGroot, J. D., Su, Y., Koeman, J., Dykema, K., Leung, S., Snider, J., Davies, S. R., Swiatek, P. J., Cottingham, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810403106 · Cited by 112
Comparative and integrative functional genomics of HCC
Lee, J.-S., & Thorgeirsson, S. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209561 · Cited by 121
Death-From-Cancer Signatures and Stem Cell Contribution to Metastatic Cancer
Glinsky, G. V. (2005) · Cell Cycle · doi:10.4161/cc.4.9.2001 · Cited by 116
Survival prediction of stage I lung adenocarcinomas by expression of 10 genes
Bianchi, F., Nuciforo, P., Vecchi, M., Bernard, L., Tizzoni, L., Marchetti, A., Buttitta, F., Felicioni, L., Nicassio, F., & Di Fiore, P. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32007 · Cited by 114
Van Meter, M. E. M., Díaz-Flores, E., Archard, J. A., Passegué, E., Irish, J. M., Kotecha, N., Nolan, G. P., Shannon, K., & Braun, B. S. (2007) · Blood · doi:10.1182/blood-2006-09-047530 · Cited by 114
The limitations of simple gene set enrichment analysis assuming gene independence
Tamayo, P., Steinhardt, G., Liberzon, A., & Mesirov, J. P. (2012) · Statistical Methods in Medical Research · doi:10.1177/0962280212460441 · Cited by 121
Self-citationA Genomic Strategy to Elucidate Modules of Oncogenic Pathway Signaling Networks
Chang, J. T., Carvalho, C., Mori, S., Bild, A. H., Gatza, M. L., Wang, Q., Lucas, J. E., Potti, A., Febbo, P. G., West, M., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.02.030 · Cited by 107
Angulo, B., Suárez‐Gauthier, A., López‐Ríos, F., Medina, P. P., Conde, E., Tang, M., Soler, G., Encuentra, Á. L., Cigudosa, J. C., & Sánchez‐Céspedes, M. (2007) · The Journal of Pathology · doi:10.1002/path.2267 · Cited by 106
NSD2 dimethylation at H3K36 promotes lung adenocarcinoma pathogenesis
Sengupta, D., Zeng, L., Li, Y., Hausmann, S., Ghosh, D., Yuan, G., Nguyen, T. N., Lyu, R., Caporicci, M., Benitez, A. M., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.034 · Cited by 109
Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction
Bertotti, A., Burbridge, M. F., Gastaldi, S., Galimi, F., Torti, D., Medico, E., Giordano, S., Corso, S., Rolland-Valognes, G., Lockhart, B. P., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000643 · Cited by 97
The challenges of gene expression microarrays for the study of human cancer
Tinker, A. V., Boussioutas, A., & Bowtell, D. D. L. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.001 · Cited by 109
A RAS Renaissance: Emerging Targeted Therapies for KRAS-Mutated Non–Small Cell Lung Cancer
Vasan, N., Boyer, J. L., & Herbst, R. S. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1762 · Cited by 102
“WT1 Targeting genes from a previously identified KRas transcriptional signature (63), as well as transcriptional regulators, Vicent and colleagues identified the Wilms tumor 1 transcription factor (WT1) as critical for oncogenic KRas”
Nguyen, A. T., Emelyanov, A., Koh, C. H. V., Spitsbergen, J. M., Lam, S. H., Mathavan, S., Parinov, S., & Gong, Z. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007831 · Cited by 108
Deeb, K. K., Michalowska, A. M., Yoon, C.-Y., Krummey, S. M., Hoenerhoff, M. J., Kavanaugh, C., Li, M.-C., Demayo, F. J., Linnoila, I., Deng, C.-X., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1515 · Cited by 102
Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice
Molyneux, S. D., Di Grappa, M. A., Beristain, A. G., McKee, T. D., Wai, D. H., Paderova, J., Kashyap, M., Hu, P., Maiuri, T., Narala, S. R., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42391 · Cited by 99
Igf1r as a therapeutic target in a mouse model of basal-like breast cancer
Klinakis, A., Szabolcs, M., Chen, G., Xuan, S., Hibshoosh, H., & Efstratiadis, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810221106 · Cited by 100
Park, E. S., Rabinovsky, R., Carey, M., Hennessy, B. T., Agarwal, R., Liu, W., Ju, Z., Deng, W., Lu, Y., Woo, H. G., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0743 · Cited by 102
Using Genetically Engineered Mouse Models of Cancer to Aid Drug Development: An Industry Perspective
Singh, M., & Johnson, L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0437 · Cited by 102
Urinary detection of lung cancer in mice via noninvasive pulmonary protease profiling
Kirkpatrick, J. D., Warren, A., Soleimany, A. P., Westcott, P. M. K., Voog, J. C., Martin-Alonso, C., Fleming, H. E., Tammela, T., Jacks, T., & Bhatia, S. N. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw0262 · Cited by 96
Self-citationBraña, I., Berger, R., Golan, T., Haluska, P., Edenfield, J., Fiorica, J., Stephenson, J. R., Martin, L. P., Westin, S. N., Hanjani, P., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.497 · Cited by 96
Cannell, I. G., Merrick, K. A., Morandell, S., Zhu, C., Braun, C. J., Grant, R. A., Cameron, E. R., Tsao, M., Hemann, M. T., & Yaffe, M. B. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.009 · Cited by 95
Novel Pheochromocytoma Susceptibility Loci Identified by Integrative Genomics
Dahia, P. L. M., Hao, K., Rogus, J., Colin, C., Pujana, M. A. G., Ross, K., Magoffin, D., Aronin, N., Cascon, A., Hayashida, C. Y., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1427 · Cited by 90
From cancer genomes to oncogenic drivers, tumour dependencies and therapeutic targets
Eifert, C., & Powers, S. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3299 · Cited by 102
Reuter, J. A., Ortiz-Urda, S., Kretz, M., Garcia, J., Scholl, F. A., Pasmooij, A. M. G., Cassarino, D., Chang, H. Y., & Khavari, P. A. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.04.002 · Cited by 88
“The CTPS is largely distinct frompreviously identified Ras signatures, sharing 10 genes with a K-Ras signature derived from a murine lung adenocarcinoma model (Sweet-Cordero et al., 2005) and 68 genes with a signature derived from H-Ras overexpression in cultured human mammary epithelial cells (Bild et al.”
Meyerson, M. M., & Carbone, D. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.15.511 · Cited by 89
Wang, I., Ustiyan, V., Zhang, Y., Cai, Y., Kalin, T. V., & Kalinichenko, V. V. (2013) · Oncogene · doi:10.1038/onc.2013.475 · Cited by 89
Learning Coordinate Covariances via Gradients
Mukherjee, S., & Zhou, D. (2006) · Journal of Machine Learning Research · Cited by 96
Self-citationGreenblatt, M. B., Sargent, J. L., Farina, G. A., Tsang, K., Lafyatis, R., Glimcher, L. H., Whitfield, M. L., & Aliprantis, A. O. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.024 · Cited by 84
Zhou, Y., Rideout, W. M., Zi, T., Bressel, A., Reddypalli, S., Rancourt, R. C., Woo, J.-K., Horner, J. W., Chin, L., Chiu, M. I., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1595 · Cited by 88
Self-citationMolecular evidence for arterial repair in atherosclerosis
Karra, R., Vemullapalli, S., Dong, C., Herderick, E. E., Song, X., Slosek, K., Nevins, J. R., West, M., Goldschmidt-Clermont, P. J., & Seo, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507718102 · Cited by 82
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations
Hammond, D. E., Mageean, C. J., Rusilowicz, E. V., Wickenden, J. A., Clague, M. J., & Prior, I. A. (2015) · Journal of Proteome Research · doi:10.1021/pr501191a · Cited by 81
Gaspar, C., Cardoso, J., Franken, P., Molenaar, L., Morreau, H. M., Möslein, G., Sampson, J. R., Boer, J. M., de Menezes, R. X., & Fodde, R. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070851 · Cited by 89
Evidence-Based Annotation of the Malaria Parasite's Genome Using Comparative Expression Profiling
Zhou, Y., Ramachandran, V., Kumar, K. A., Westenberger, S. J., Refour, P., Zhou, B., Li, F., Young, J. A., Chen, K., Plouffe, D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001570 · Cited by 80
Shields, J. M., Thomas, N. E., Cregger, M., Berger, A. J., Leslie, M., Torrice, C., Hao, H., Penland, S., Arbiser, J., Scott, G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3311 · Cited by 81
Kaminski, N., & Rosas, I. O. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-011tk · Cited by 88
RAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally
Miller, M. S., & Miller, L. D. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2011.00100 · Cited by 76
Modeling Cancer Progression via Pathway Dependencies
Edelman, E. J., Guinney, J., Chi, J., Febbo, P. G., & Mukherjee, S. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0040028 · Cited by 84
Self-citationYAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma
Tu, B., Yao, J., Ferri-Borgogno, S., Zhao, J., Chen, S., Wang, Q., Yan, L., Zhou, X., Zhu, C., Bang, S., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.130811 · Cited by 75
Pharmacogenomic Predictor Discovery in Phase II Clinical Trials for Breast Cancer
Pusztai, L., Anderson, K., & Hess, K. R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0809 · Cited by 74
Molecular Credentialing of Rodent Bladder Carcinogenesis Models
Williams, P. D., Lee, J. K., & Theodorescu, D. (2008) · Neoplasia · doi:10.1593/neo.08432 · Cited by 73
Zheng, W., Li, Z., Nguyen, A. T., Li, C., Emelyanov, A., & Gong, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091179 · Cited by 73
A gene transcription signature of the Akt/mTOR pathway in clinical breast tumors
Creighton, C. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210245 · Cited by 73
Edelman, E., Porrello, A., Guinney, J., Balakumaran, B., Bild, A., Febbo, P. G., & Mukherjee, S. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl231 · Cited by 75
Self-citationHaining, W. N., Ebert, B. L., Subrmanian, A., Wherry, E. J., Eichbaum, Q., Evans, J. W., Mak, R., Rivoli, S., Pretz, J., Angelosanto, J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1859 · Cited by 70
Self-citationZhou, Y., Zhu, J., Tong, T., Wang, J., Lin, B., & Zhang, J. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2745-1 · Cited by 74
Qian, C., Furge, K. A., Knol, J., Huang, D., Chen, J., Dykema, K. J., Kort, E. J., Massie, A., Khoo, S. K., Beldt, K. V., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1689 · Cited by 67
Genomics and proteomics: Emerging technologies in clinical cancer research
Chung, C. H., Levy, S., Chaurand, P., & Carbone, D. P. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.06.005 · Cited by 74
Identification of mutant K-Ras-dependent phenotypes using a panel of isogenic cell lines
Vartanian, S., Bentley, C., Brauer, M. J., Li, L., Shirasawa, S., Sasazuki, T., Kim, J.-S., Haverty, P., Stawiski, E., Modrusan, Z., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.394130 · Cited by 65
Mass mortality in Pacific oysters is associated with a specific gene expression signature
Chaney, M. L., & Gracey, A. Y. (2011) · Molecular Ecology · doi:10.1111/j.1365-294x.2011.05152.x · Cited by 65
Profiling Studies in Ovarian Cancer: A Review
Fehrmann, R. S. N., Li, X., van der Zee, A. G. J., de Jong, S., Meerman, G. J. T., de Vries, E. G. E., & Crijns, A. P. G. (2007) · The Oncologist · doi:10.1634/theoncologist.12-8-960 · Cited by 69
Bild, A., & Febbo, P. G. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507477102 · Cited by 65
Downward, J. (2006) · Nature · doi:10.1038/439274a · Cited by 64
Comparative Microarray Analysis
Larsson, O. S., Wennmalm, K., & Sandberg, R. (2006) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2006.10.381 · Cited by 72
Expression of EWS-ETS Fusions in NIH3T3 Cells Reveals Significant Differences to Ewing’s Sarcoma
Braunreiter, C. L., Hancock, J. D., Coffin, C. M., Boucher, K. M., & Lessnick, S. L. (2006) · Cell Cycle · doi:10.4161/cc.5.23.3505 · Cited by 62
Gene expression profiling of Non-small cell lung cancer
Singhal, S. K., Miller, D., Ramalingam, S. S., & Sun, S. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.03.007 · Cited by 62
Zhang, W., Zeng, Z., Zhou, Y., Xiong, W., Fan, S., Xiao, L., Huang, D., Li, Z., Li, D. C., Wu, M., et al. (2009) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmp025 · Cited by 59
Imaging Primary Lung Cancers in Mice to Study Radiation Biology
Kirsch, D. G., Grimm, J., Guimarães, A. R., Wojtkiewicz, G. R., Perez, B. A., Santiago, P. M., Anthony, N. K., Forbes, T., Doppke, K. P., Weissleder, R., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.11.038 · Cited by 58
Self-citationYang, W., Harris, M. A., Heinrich, J. G., Guo, D., Bonewald, L. F., & Harris, S. E. (2009) · Bone · doi:10.1016/j.bone.2008.08.133 · Cited by 57
Mouse Models of Human Non-Small-Cell Lung Cancer: Raising the Bar
KIM, C. F. B., JACKSON, E. L., KIRSCH, D. G., GRIMM, J., SHAW, A. T., LANE, K., KISSIL, J., OLIVE, K. P., SWEET-CORDERO, A., WEISSLEDER, R., et al. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.037 · Cited by 58
Self-citationEffects of Antioxidants in Human Cancers: Differential Effects on Non-Coding Intronic RNA Expression
Menon, S., Lü, C., Menon, R., Schwartz, J., & Guan, Y. (2016) · Antioxidants · doi:10.3390/antiox5010001 · Cited by 57
Ramos, M.-P., Wijetunga, N. A., McLellan, A. S., Suzuki, M., & Greally, J. M. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0004-x · Cited by 61
Wu, M. C., & Lin, X. (2009) · Statistical Methods in Medical Research · doi:10.1177/0962280209351925 · Cited by 66
Cardó‐Vila, M., Giordano, R. J., Sidman, R. L., Bronk, L. F., Fan, Z., Mendelsohn, J. M., Arap, W., & Pasqualini, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915146107 · Cited by 59
Characterizing the developmental pathways TTF-1 , NKX2–8 , and PAX9 in lung cancer
Hsu, D. S., Acharya, C. R., Balakumaran, B. S., Riedel, R. F., Kim, M. K., Stevenson, M. M., Tuchman, S. A., Mukherjee, S., Barry, W. T., Dressman, H. K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900827106 · Cited by 61
Self-citationBRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
Nakayama, I., Hirota, T., & Shinozaki, E. (2020) · Cancers · doi:10.3390/cancers12113236 · Cited by 65
Integrating Genomic Signatures for Immunologic Discovery
Haining, W. N., & Wherry, E. J. (2010) · Immunity · doi:10.1016/j.immuni.2010.02.001 · Cited by 59
A Mouse Stromal Response to Tumor Invasion Predicts Prostate and Breast Cancer Patient Survival
Bacac, M., Provero, P., Mayran, N., Stehle, J.-C., Fusco, C., & Stamenkovic, I. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000032 · Cited by 53
Balamuth, N., Wood, A., Wang, Q., Jagannathan, J., Mayes, P. A., Zhang, Z., Chen, Z., Rappaport, E. R., Courtright, J., Pawel, B., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3844 · Cited by 54
Genomic Approaches to Lung Cancer
Thomas, R. K., Weir, B. A., & Meyerson, M. M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0098 · Cited by 59
Furge, K. A., Tan, M.-H., Dykema, K. J., Kort, E. J., Stadler, W. M., Yao, X., Zhou, M., & Teh, B. T. (2007) · Oncogene · doi:10.1038/sj.onc.1210256 · Cited by 53
Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models
Herter-Sprie, G. S., Korideck, H., Christensen, C. L., Herter, J. M., Rhee, K., Berbeco, R. I., Bennett, D. G., Akbay, E. A., Kozono, D., Mak, R. H., et al. (2014) · Nature Communications · doi:10.1038/ncomms6870 · Cited by 53
Protein Kinase C δ Is a Downstream Effector of Oncogenic K-ras in Lung Tumors
Symonds, J. M., Ohm, A. M., Carter, C. J., Heasley, L. E., Boyle, T. A., Franklin, W. A., & Reyland, M. E. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1511 · Cited by 50
Toward personalized cancer nanomedicine – past, present, and future
Stegh, A. H. (2012) · Integrative Biology · doi:10.1039/c2ib20104f · Cited by 55
EGF receptor mutations in lung cancer: From humans to mice and maybe back to humans
Arteaga, C. L. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.014 · Cited by 57
Progress and applications of mouse models for human lung cancer
Seranno, S. D., & Meuwissen, R. L. J. (2010) · European Respiratory Journal · doi:10.1183/09031936.00124709 · Cited by 58
In the pursuit of complexity: Systems medicine in cancer biology
Liu, E. T., Kuznetsov, V. A., & Miller, L. D. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.026 · Cited by 50
Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinoma
Valdmanis, P. N., Roy‐Chaudhuri, B., Kim, H.-X., Sayles, L. C., Zheng, Y., Chuang, C.-H., Caswell, D. R., Chu, K. P.-M., Zhang, Y., Winslow, M. M., et al. (2013) · Oncogene · doi:10.1038/onc.2013.523 · Cited by 51
Self-citationLucas, J. E., Kung, H.-N., & Chi, J.-T. A. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000920 · Cited by 49
A novel method for cross-species gene expression analysis
Kristiansson, E., Österlund, T., Gunnarsson, L. M., Arne, G., Larsson, D. G. J., & Nerman, O. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-70 · Cited by 55
Multiple Oncogenic Pathway Signatures Show Coordinate Expression Patterns in Human Prostate Tumors
Creighton, C. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001816 · Cited by 48
Overview of the Molecular Carcinogenesis of Mouse Lung Tumor Models of Human Lung Cancer
Wakamatsu, N., Devereux, T. R., Hong, H. L., & Sills, R. C. (2007) · Toxicologic Pathology · doi:10.1080/01926230601059993 · Cited by 50
Floyd, H. S., Farnsworth, C. L., Kock, N. D., Mizesko, M. C., Little, J. L., Dance-Barnes, S. T., Everitt, J. I., Tichelaar, J. W., Whitsett, J. A., & Miller, M. S. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi190 · Cited by 47
Comparison of gene expression and DNA copy number changes in a murine model of lung cancer
Sweet‐Cordero, A., Tseng, G. C., You, H., Douglass, M., Huey, B., Albertson, D., & Jacks, T. (2006) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20296 · Cited by 45
“We analyzed the gene expression profiles of these tumors and compared them to human lung cancer gene expression profiles (Sweet-Cordero et al., 2004).”
BackgroundResultSelf-citationCastellano, E., Rivas, J. D. L., Guerrero, C., & Santos, E. (2006) · Oncogene · doi:10.1038/sj.onc.1209845 · Cited by 45
ASSIGN: context-specific genomic profiling of multiple heterogeneous biological pathways
Shen, Y., Roosan, M. R., Piccolo, S., Gusenleitner, D., El-Chaar, N. N., Cheng, L., Monti, S., Bild, A. H., & Johnson, W. E. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv031 · Cited by 45
Guo, J., Chu, M., Abbeyquaye, T., & Chen, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504688200 · Cited by 52
Canine Mammary Carcinomas: A Comparative Analysis of Altered Gene Expression
Kabir, F. M. L., Alvarez, C. E., & Bird, R. (2015) · Veterinary Sciences · doi:10.3390/vetsci3010001 · Cited by 47
Yeddula, N., Xia, Y., Ke, E., Beumer, J., & Verma, I. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520110112 · Cited by 43
Jung, H.-K., Park, S., Gunassekaran, G. R., Jeon, M., Cho, Y., Baek, M., Park, J. Y., Shim, G., Oh, Y., Kim, I.-S., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3089 · Cited by 42
RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma
East, P., Kelly, G. P., Biswas, D., Marani, M., Hancock, D. C., Creasy, T. H., Sachsenmeier, K. F., Swanton, C., Downward, J., & Trécesson, S. D. C. (2022) · Nature Communications · doi:10.1038/s41467-022-33290-0 · Cited by 43
Frau, M., Simile, M. M., Tomasi, M. L., Demartis, M. I., Daino, L., Seddaiu, M. A., Brozzetti, S., Feo, C. F., Massarelli, G., Solinas, G., et al. (2012) · Cellular Oncology · doi:10.1007/s13402-011-0067-z · Cited by 46
Kong, Y. W., Dreaden, E. C., Morandell, S., Zhou, W., Dhara, S. S., Sriram, G., Lam, F. C., Patterson, J. C., Quadir, M., Dinh, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17958-z · Cited by 43
Itadani, H., Mizuarai, S., & Kotani, H. (2008) · Current Genomics · doi:10.2174/138920208785133235 · Cited by 50
O’Donnell, E. P., Zerbe, L. K., Dwyer‐Nield, L. D., Kisley, L. R., & Malkinson, A. M. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.10.012 · Cited by 41
Metadata
- Authors
- Sweet-Cordero, A., Mukherjee, S., Subramanian, A., You, H., Roix, J. J., Ladd-Acosta, C., Mesirov, J., Golub, T. R., & Jacks, T.
- Affiliations
- Massachusetts Institute of Technology (US)
- Broad Institute (US)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Jacks, Tyler
- ORCID
- Venue
- Nature Genetics
- Published
- 2004-12-19
- Volume
- 37
- Issue
- 1
- Pages
- 48-55
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2111476798
- Cited by
- 414
- References
- 38
- Citations by year
- 2025: 2 · 2024: 7 · 2023: 16 · 2022: 8 · 2021: 11 · 2020: 9 · 2019: 8 · 2018: 7 · 2017: 5 · 2016: 12 · 2015: 18 · 2014: 14 · 2013: 25 · 2012: 29
- FWCI
- 13.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- KRAS2, oncogenic KRAS, gene expression signatures, mouse tumor model, lung adenocarcinoma, KRAS mutation, shRNA, gene expression profiling, tumor progression, model validation
- MeSH terms
- Adenocarcinoma, Animals, Lung Neoplasms, Proto-Oncogene Proteins, Species Specificity, Gene Expression, Proto-Oncogene Proteins p21(ras), ras Proteins, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.